These rates were significantly lower compared with rates in BRCA2 carriers who did not have FA diagnosed with BC (24.9%, p ≈ 0.013), and for all BRCA carriers combined—FA diagnosis has shown an independent protective effect (OR ≈ 0.21, CI [0.10–0.44], p < 0.001). The gene discussed is BRCA2; the disease is breast cancer.